Helius Medical Technologies, Inc. (HSDT) Tops Q2 EPS by 15c

Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.97), $0.15 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $119 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Goldman Sachs Reiterates Buy Rating on Braze Inc (BRZE)
• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance